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ABSTRACT
Background: Zinc (Zn) as an important trace element is essential for testicular development and 
spermatogenesis. Molecular mechanism of Zn action in the reproductive system may be related to metal 
binding low-molecular weight proteins, metallothioneins (MT). Our objective was to determine the effect of 
Zn on two important isoforms of MT, MT1M and MT1G genes expression on testicular sertoli cells. 
Methods: Cultured sertoli TM4 cells were exposed to different concentrations of Zn at different time points. 
Cellular uptake of Zn was tested using flame atomic absorption spectrometry. The cellular viability and gene 
expression were assessed by MTT and real-time PCR methods, respectively. Results: The treated cells 
resulted in higher Zn concentration and cellular viability. The expression of MT1M and MT1G genes in the 
treated cells were greater than those of the untreated cells (P<0.05). In the high dosage treated group (100 and 
500 μM), Zn concentration and expression of MT1M and MT1G genes increased three h after treatment; 
MT1G gene expression increased more at sixth h. At 18th h of treatment, the expression of both genes
especially MT1G, increased dramatically while Zn concentration decreased. Conclusion: Since the increase 
of MT1G mRNA was coincident with cellular Zn level, it seems that MT1G has a more prominent role than 
MT1M in the homeostasis of Zn. In addition, Zn at dosage of 50 μM (pharmacologic concentration) may
protect cells by increasing the expression of MT genes at longer periods.  Iran. Biomed. J. 14 (1 & 2): 9-15, 2010
Keywords: Gene expression, Metallothionein (MT), Sertoli cells, Zinc
INTRODUCTION
inc (Zn) is an important trace element which 
plays a role in protein and nucleic acid 
synthesis and participates as a key regulator 
in all mammalian cells [1-3]. Zn ion has been shown 
to be essential for testicular development and 
spermatogenesis [1, 4]. In the male reproductive 
system, Zn ion facilitates the unique packaging of 
DNA in spermatocytes and participates in 
development and function of sperm [3].  Zn 
deficiency is known to result in oligoazospermia, 
impotency and hypogonadism in rats and men. 
Besides, some studies have demonstrated that Zn 
supplementation reduces astenoazospermia [4, 5]. 
The underlying molecular mechanism of Zn action 
in the reproductive system still remains unknown. It 
has been advocated that Zn and low molecular 
weight proteins, metallothioneins (MT), might play 
a role [6, 7]. MT proteins, rich in cysteine residues, 
are involved in metal homeostasis and scavenging 
free oxygen radicals [8-10]. By regulating Zn 
availability to the Zn finger region, this protein can 
regulate activation of certain transcription factors
[11, 12].
On the structural basis, MT have been divided into 
different classes and their most conspicuous 
biological feature is their inducibility by a variety of 
agents and conditions [13, 14]. Between the MT 
proteins which can act as a reservoir and donor of 
Z
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Zn, the actions of two important isoforms, MT1M 
and MT1G, are very important [9, 15, 16]. In 
addition, because of the importance of Zn, induction 
of MT biosynthesis by this ion has been emphasized 
[17, 18]. 
Since male genital organs, particularly testis, are 
extremely susceptible to toxicants like cadmium
(Cd), the presence of MT and their induction by Zn
may protect spermatogenesis [6, 16, 19, 20]. Sertoli 
cells as supportive cells in seminiferous epithelium
have a critical role in spermatogenesis. These cells 
can coordinate nutritional and structural support to 
germ cells [6]. This support could be critical in 
providing transcription and growth factor 
compounds which are Zn related [9, 21, 22]. Indeed, 
sertoli cells form a physiological barrier and limit 
exposure to potentially toxic substances [23]. In 
these cells, the induction of these genes by Zn has 
been debated [15, 24-27]. Thus, in the current study, 
we have analyzed the effect of different Zn 
concentrations on the expression of two major 
isoforms of MT, MT1M and MT1G genes, using 
different timing in mouse testicular sertoli cells.
MATERIALS AND METHODS
Cell culture and Zn treatment. Sertoli TM4 cells 
(ATCC number CRL-1715) were cultured as 
described by the ATCC protocol.  Zn dilution was 
prepared from a 10 mM stock ZnSO4 solution and 
Zn treatment was performed according to the Chang
et al. [28] at physiologic (2 μM), pharmacologic (20, 
50 and 100 μM) and toxic (500 μM) concentrations. 
The cultured cells were treated with the designated 
amount of Zn for 1, 2, 3, and 6 h, except the cells 
treated with 50 μM (pharmacologic dosage) for 18 h. 
Cellular viability assay. Cellular viability in the 
presence or absence of Zn was determined using the 
MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-dimethyl 
tetrazolium bromide (Sigma, USA)] assay. Briefly, 
following Zn treatment, 100 μL of culture medium 
containing MTT solution was added to each well (10
 105 cells), and the plate was incubated at 37ºC for 
two h. The medium was then removed and the 
colored reaction product was solubilized in 100 μL 
DMSO. Absorbance was measured at 570 nm using 
an ELISA reader (Anthos 2020, Austria) and the 
percentage of viability was calculated. 
Zn determination. Both treated and untreated cells 
(10  105 cells) were washed twice with ice-cold 
PBS and then total Zn concentration was determined 
by flame atomic absorption spectrometry using a 
Spectra AA-220 (Varian, Australia). 
RNA extraction and reverse transcriptase PCR
(RT-PCR). The remaining washed cells (10  105
cells) were removed and centrifuged twice at 1600
g for 5 min. Total RNA was extracted from the cell 
pellet by the High Pure RNAgents Isolation kit 
(Promega, UK) as described by the manufacturer. 
Then, RNA was eluted with 20 µl RNase and DNase 
free distilled water and stored in aliquots at -80ºC. 
Purity of RNA was estimated by the absorbance 
ratio A260/A280 nm (The ratio for RNA was 1.8-2). 
RNA integrity was confirmed by ethidium bromide 
staining of ribosomal RNA following gel electro-
phoresis. Synthesis of cDNA was performed 
according to the previous report [29]. For primer 
designing, human sequences for MT1M and MT1G 
genes and their mouse homologues (Mt1 and Mt2
genes) were aligned. The identical sequences were
selected for primer designation (Table 1) and beta 
actin gene was used as a housekeeping gene. The 
MT genes were amplified in a multiplex RT-PCR 
protocol in this way: initial heating at 95°C for 5
min, followed by 30 cycles of 95°C for 30 s, 62.5°C 
for 30s, and 72°C for 20s. Amplified products were 
subjected to electrophoresis in 2% agarose gels and 
visualized with ethidium bromide (Fig. 1).
Quantitative real-time RT-PCR analysis. The 
real-time PCR was carried out with QuantiFast 
SYBR Green Kit (Roche Applied Science, UK) 
using 1 µl of cDNA (equivalent to 100 ng cDNA) in 
a 20 µl final volume and 0.4 µM of each primer 
(final concentration). Quantitative PCR was
performed using a Corbett Rotor-Gene 3000 for 35
cycles at 95ºC for 10s and at 60ºC for 20s. 
Specificity of product for each separate sample was
checked with the melting curve analysis and 
quantification was achieved with the comparative 
threshold cycle method.
  Table 1. Sequences of the primers used in real-time PCR 
assays.
Gene name Sequence
Product 
size (bp)
Metallothionein 1 ATGGACCCCAACTGCTCCTG 197
TTCGTCACATCAGGCACAGC
Metallothionein 2 ACCCCAACTGCTCCTGTGCC 127
CACTTCGCACAGCCCACGG
Beta actin GCTATGCTCTCCCTCACGCCA 162
CCACTGCCGCATCCTCTTCCT
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Fig. 1. Gene expression of Mt1 and Mt2 genes in untreated 
testicular sertoli cells (left side), 100 bp ladder (right side). 
Statistical analysis. For statistical analysis, 
Kruskal-Wallis test, One-Way ANOVA, Mann-
Whitney U test and independent t-test were 
performed. A P value of 0.05 was considered for 
significant difference. 
Microscopic observations. Under an inverted 
microscope (Euromex, Holland), cells treated with 
physiologic and pharmacologic dosage of Zn did not 
show any significant morphological changes 
indicative toxicity. However, cells treated with 500
μM of Zn revealed a transformed round shape 
cellular morphology (Fig. 2).
RESULTS
Determination of Zn uptake in sertoli cells. The 
mean of Zn concentration in treated cells was 0.16 ± 
0.14 ppm in comparison with 0.08 ± 0.01 ppm in 
untreated cells (P<0.05). For evaluating Zn uptake at 
different dosages of treatment, we calculated the 
percentage of concentration. As shown in Figure 3A, 
Zn concentration inside the treated cells increased by 
accretion of treatment dosage, although the increase 
was subtle in cells treated with 2, 20, and 50 μM of 
Zn. Three and six h after treatment  with 100 μM,
Zn concentration was about double. At toxic dosage 
treated cells (500 μM), it increased much more, 
particularly six h after treatment. According to
Figure 3B, in the cells treated with 50 μM 
(pharmacologic concentration), Zn level increased
by six h of treatment, then at the 18th h, it decreased
and reached at its initial value (P<0.05).
Effect of Zn treatment on viability of sertoli TM4
cells. The mean value of cellular viability was 
significantly (P<0.05) higher (158 ± 52%) compared 
to untreated cells. As seen in Figure 4, at sixth h of 
treatment, the cellular viability was high for those 
cells treated with 2, 20 and 50 μM, but it was 
apparently dropped by increasing dosage (up to 100
μM) and reached near the values of control cells at 
toxic (500 μM) treatment dosage (P<0.05). 
Effects of Zn on the MT genes expression in 
sertoli cells. Relative MT genes expression in the 
Zn-treated cells (pharmacologic and toxic dosage)
was approximately doubled compared to the 
untreated cells (P<0.05). The mean value of relative 
MT1M gene expression in the treated cells was 1.06
± 0.75 compared to the untreated cells (0.60 ± 0.33). 
For MT1G gene expression, this value was 1.79 ± 
1.44 compared to the untreated cells (0.77 ± 0.4). As
shown in Figure 5A, we considered percentage of 
relative expression for MT1M and MT1G genes at
Fig. 2. Toxic dosage of Zn-treated (A) and untreated cells (B). 
The cultured cells six h after treatment with toxic concentration 
of Zn (500 μM) resulted in a circular morphology (A) compared
to the conical shape of untreated cells (B). 
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different dosages of treatment. There was no 
obvious difference in the levels of mRNA with low 
dosage treatment group (2, 20 anf 50 μM) but they 
increased three h after high dosage (100, 500μM) 
treatment. After that, at the sixth h of treatment in 
the cells treated with 100 μM, expression of both 
genes increased dramatically and in the cells treated 
with 500 μM, gene expression of MT1M   
diminished, but in the case of MT1G, it increased. 
The effect of time on the expression of MT1M and 
MT1G genes in the cells treated with 50 μM 
(pharmacologic concentration) revealed that 
expression of both genes enhanced by increasing 
duration of treatment (Fig. 5B). The amount of 
increase in the expression of both genes was 
significantly high after 18 h post treatment compared 
to the untreated cells or the first h of treatment (i.e. 
up to six h) (P<0.05).
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Fig. 3. Cellular uptake of Zn at different dosage of treatment 
(A) and different time (B) in sertoli TM4 cells. Cells exposed to 
different concentrations of Zn (2, 20, 50, 100 and 500 μM) for 
different periods (1, 2, 3 and 6 h). Intracellular Zn concentration 
was determined by atomic absorption spectrometry in different 
dosage of treatment (A) and it was determined in the cells 
exposed to pharmacologic concentration of Zn (50 μM) in the 
longer period (18 h); (B) data are mean ± SE.
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Fig. 4. Zn concentration impacts on viability of sertoli TM4
cells.  MTT assay was done for assessing cellular viability when 
exposing to different concentrations of Zn (2, 20, 50, 100 and 
500 μM) for different periods (1, 2, 3 and 6 h). Data are mean ± 
SE.
DISCUSSION
In this report, we showed that Zn could induce MT
genes expression in sertoli cells and also by 
increasing the Zn dosage, the levels of expression 
increased. Of course, the induction of MT genes in 
sertoli cells has been a matter of some controversy, 
since a number of reports indicated that Zn and Cd
caused induction of these genes in sertoli cells, while 
others showed that these elements could not induce 
MT genes in sertoli cells whereas they caused their 
induction in hepatic and ovarian cells [15, 24-27].  
The increase in MT genes expression was
especially important in the cells exposed to 
pharmacologic concentration of Zn (50 μM) after 
long periods of treatment (18 h). Cellular viability 
and Zn concentration in these cells were about the 
level of untreated cells. These findings implicate that 
pharmacologic dosage of Zn can make cells more 
resistant to subsequent toxicity by an increase in MT 
genes expression.
Notably, our results showed the degree of 
accretion was time and dose dependent which was in 
agreement with the results of Ren et al. [6] as they 
found similar results on the Cd effect on MT genes 
[6], thus raising speculation on the similarity of 
effects of Zn and Cd in testis. Cd causes many
problems like infertility and tumors in the testis.
On the other hand, Zn is known to provide
protective action against the toxic effects of Cd [16,
30]. Although the precise mechanism of its action is 
unknown, the above explanations bring to mind that 
the interaction of these two elements on induction of 
250
2 0
150
100
  50
    0
Z
in
c
co
nc
en
tr
at
io
n 
(%
)
(A)
(B)
6 0
5 0
4 0
3 0
2 0
1 0
    0
                  2                  20             50            100          500
Z
in
c
co
nc
en
tr
at
io
n 
(%
)
Treatment dosage (µM)
        1                 2                3                6               18
Duration of contact (h)
4 0
350
3 0
250
200
150
100
  50
     0
C
el
lu
la
r 
vi
ab
ili
ty
(%
)
Treatment dosage (µM)
       2                 20               50               100               500
Iran. Biomed. J., January & April 2010        Zinc and Metallothionein Gene Expression in Sertoli TM4 Cells                                      13
http://IBJ.pasteur.ac.ir
(A)
0
200
400
600
800
1000
1200
1400
2 20 50 100 500
Mt1M gene expression after 1 h
Mt1G gene expression after 1 h
Mt1M gene expression after 2 h
Mt1G gene expression after 2 h
Mt1M gene expression after 3 h
Mt1G gene expression after 3 h
Mt1M gene expression after 6 h
Mt1G gene expression after 6 h
Fig. 5. Expression of MT1M and MT1G genes in different 
dosage of treatments (A) and different time (B). Gene 
expression of cells exposing to different concentrations of Zn (2, 
20, 50, 100 and 500 μM) at different periods (1, 2, 3, 6 and 18 h) 
was determined by real-time PCR method (A). At longer period 
(18 h), only pharmacologic concentration of Zn (50 μM) was 
added to the cells and their expression was assessed after 1, 2, 3, 
6 and 18 h (B). 
MT genes may be the basic mechanism of Zn 
protection against Cd toxicity [26].
Since in the toxic dosage treated cells, the increase 
of MT1G mRNA was coincident with cellular Zn 
level, MT1G might have a more prominent role than 
MT1M in the homeostasis of Zn. Meanwhile, 
intensive increasing in MT1G gene expression in the 
cells treated with 500 μM and simultaneous increase 
in Zn level could be due to the failure of this 
mechanism to defeat toxic Zn concentration, which 
caused a decrease in cellular viability. In this 
dosage, decrease in the expression of MT1M gene 
showed that toxic dosage might cease this gene 
expression.
Data from MTT examination also indicated that 
cellular viability in the toxic dosage-treated group 
decreased to basal level after six h of treatment, but 
other dosages of Zn treatment did not reduce it. 
Apparently, lack of reduction in cellular viability 
of non-toxic Zn-treated cells was due to regulation 
of Zn availability by homeostatic mechanism like 
MT.
In the presence of toxic levels of Zn in cultured 
medium, shapes of sertoli cells became round. In 
fact at this level of Zn, intercellular junctions 
became loose as indicated by Ren et al. [6] with low 
concentration of Cd. Probably, a toxic dosage of Zn 
like Cd disrupted the inter sertoli tight junctions.
Nevertheless, in humans, because of the existence of 
a large number of proteins and transporters for Zn 
homeostasis, toxic doses are very rare and may be 
achieved only under the most unusual circumstances
[31, 32]. These transporters may also affect the rate 
of Zn transmission in the blood-testis barrier [33].   
We also found that MT1M and MT1G mRNA are 
present in the sertoli cells at the basal level as 
confirmed by others in relation to Mt1 and Mt2 [6, 
27]. Of course, according to the some studies, 
although testis from sexually mature adults contain 
high levels of Mt1 and Mt2 mRNA, their 
localization in different population of cells varies
[16, 27, 34]. A number of studies showed that MT 
mRNA is present in the sertoli cells, while others 
reported that there were little or no levels of MT
RNA in these cells [25, 27, 35, 36].
However, we believe that for an exact examination 
and for evaluation of the effects of Zn at different 
dosages especially in pharmacologic dosage, a 
more comprehensive study over a longer period is 
needed.
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